The silencing of GPR78 expression via siRNA in prostate cancer cells (in bone metastatic PCa cell line, PC3) reduces the level of the adhesion protein N-cadherin (N-cad), the participation of which has already been confirmed in metastasis and castration resistance PCa cells. This evidence concerns the gene GPR78 and prostate carcinoma.